KYORIN Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3247090008
JPY
1,107.00
3 (0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
29,654.00
33,801.00
33,725.00
28,502.00
30,229.00
40,801.00
34,147.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
29,654.00
33,801.00
33,725.00
28,502.00
30,229.00
40,801.00
34,147.00
Raw Material Cost
17,475.00
21,713.00
19,091.00
16,870.00
16,970.00
19,942.00
19,044.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
59.00
70.00
59.00
61.00
64.00
70.00
49.00
Selling and Distribution Expenses
8,832.00
8,606.00
9,300.00
9,188.00
8,901.00
8,952.00
9,330.00
Other Expenses
232.20
445.60
203.20
339.10
192.70
238.90
416.20
Total Expenditure (Excl Depreciation)
28,688.00
34,845.00
30,482.00
29,510.00
27,862.00
31,353.00
32,585.00
Operating Profit (PBDIT) excl Other Income
966
-1044
3243
-1008
2367
9448
1562
Other Income
334.00
43.00
309.00
418.00
326.00
27.00
189.00
Operating Profit (PBDIT)
2,444.00
217.00
4,719.00
548.00
3,833.00
10,652.00
2,870.00
Interest
59.00
70.00
59.00
61.00
64.00
70.00
49.00
Exceptional Items
-52.00
0.00
0.00
-49.00
100.00
-204.00
-2.00
Gross Profit (PBDT)
12,179.00
12,088.00
14,634.00
11,632.00
13,259.00
20,859.00
15,103.00
Depreciation
1,144.00
1,218.00
1,167.00
1,138.00
1,140.00
1,177.00
1,119.00
Profit Before Tax
1,187.00
-1,073.00
3,495.00
-699.00
2,728.00
9,201.00
1,700.00
Tax
363.00
-402.00
869.00
-93.00
628.00
2,554.00
517.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
824.00
-671.00
2,625.00
-606.00
2,100.00
6,647.00
1,184.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
824.00
-671.00
2,625.00
-606.00
2,100.00
6,647.00
1,184.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
824.00
-671.00
2,625.00
-606.00
2,100.00
6,647.00
1,184.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,40,304.00
1,42,425.00
1,38,869.00
1,36,448.00
1,36,153.00
1,36,285.00
1,30,073.00
Earnings per share (EPS)
14.34
-11.68
45.69
-10.55
36.55
115.7
20.61
Diluted Earnings per share
14.34
-11.68
45.69
-10.55
36.55
115.7
20.61
Operating Profit Margin (Excl OI)
3.26%
-3.09%
9.62%
-3.54%
7.83%
23.16%
4.57%
Gross Profit Margin
7.86%
0.43%
13.82%
1.54%
12.8%
25.44%
8.26%
PAT Margin
2.78%
-1.99%
7.78%
-2.13%
6.95%
16.29%
3.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -12.27% vs 0.23% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 222.80% vs -125.56% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 1,112.64% vs -96.05% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -15.71% vs 18.64% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of KYORIN Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
29,654.00
7,654.00
22,000.00
287.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
29,654.00
7,654.00
22,000.00
287.43%
Raw Material Cost
17,475.00
2,163.00
15,312.00
707.91%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
59.00
485.00
-426.00
-87.84%
Selling and Distribution Expenses
8,832.00
3,383.00
5,449.00
161.07%
Other Expenses
232.20
248.70
-16.50
-6.63%
Total Expenditure (Excl Depreciation)
28,688.00
8,518.00
20,170.00
236.79%
Operating Profit (PBDIT) excl Other Income
966.00
-864.00
1,830.00
211.81%
Other Income
334.00
-502.00
836.00
166.53%
Operating Profit (PBDIT)
2,444.00
-271.00
2,715.00
1,001.85%
Interest
59.00
485.00
-426.00
-87.84%
Exceptional Items
-52.00
0.00
-52.00
Gross Profit (PBDT)
12,179.00
5,491.00
6,688.00
121.80%
Depreciation
1,144.00
1,095.00
49.00
4.47%
Profit Before Tax
1,187.00
-1,849.00
3,036.00
164.20%
Tax
363.00
-1,442.00
1,805.00
125.17%
Provisions and contingencies
0
0
0.00
Profit After Tax
824.00
-202.00
1,026.00
507.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
824.00
-202.00
1,026.00
507.92%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
824.00
-202.00
1,026.00
507.92%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,40,304.00
64,803.00
75,501.00
116.51%
Earnings per share (EPS)
14.34
-2.21
16.55
748.87%
Diluted Earnings per share
14.34
-2.21
16.55
748.87%
Operating Profit Margin (Excl OI)
3.26%
-11.29%
0.00
14.55%
Gross Profit Margin
7.86%
-9.85%
0.00
17.71%
PAT Margin
2.78%
-2.64%
0.00
5.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,965.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -12.27% vs 0.23% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -1.90% vs 6.37% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 82.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 222.80% vs -125.56% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -60.76% vs 137.29% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 211.00 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1,112.64% vs -96.05% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -39.83% vs 50.71% in Jun 2025

Quarterly - Interest
Interest 5.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -15.71% vs 18.64% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -7.81% vs 255.56% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.26%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025